Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Helixia Kids Natural Defense is a natural health product marketed by Norwell Consumer Healthcare (a division of Pharmascience) in Canada. The product's primary active ingredient is **pleururan**, a standardized beta-1,3/1,6-D-glucan extract derived from the oyster mushroom (*Pleurotus ostreatus*). It is specifically formulated for children to support immune system function and help reduce the frequency of recurrent respiratory tract infections. Pleururan acts as an immunomodulator by interacting with Dectin-1 receptors on innate immune cells in the gut-associated lymphoid tissue (GALT), thereby priming the immune response without causing overstimulation. It is available as an oral suspension and is approved for use in children aged 3 to 12 years.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on pleururan.